REVANCE THERAPEUTICS INC shareholders Q4 2022

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Schonfeld Strategic Advisors LLC 171,351$3,163,1390.03%
FRANKLIN RESOURCES INC 2,384,590$44,019,5310.02%
HighTower Advisors, LLC 491,442$9,071,0000.02%
PUBLIC SECTOR PENSION INVESTMENT BOARD 134,000$2,473,6400.02%
GILDER GAGNON HOWE & CO LLC 52,939$977,2540.02%
DENALI ADVISORS LLC 2,300$42,4580.02%
Princeton Global Asset Management LLC 2,500$460.02%
Freestone Capital Holdings, LLC 18,020$332,6490.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 123,821$2,285,7360.02%
TUDOR INVESTMENT CORP ET AL 41,076$7580.02%
Qube Research & Technologies Ltd 141,880$2,619,1050.01%
Perfromance Wealth Partners, LLC 13,000$239,9800.01%
Quantbot Technologies LP 10,772$198,8510.01%
Assenagon Asset Management S.A. 192,359$3,5510.01%
JPMORGAN CHASE & CO 5,014,422$92,5670.01%
TILIA FIDUCIARY PARTNERS, INC. 600$11,0760.01%
BLAIR WILLIAM & CO/IL 125,505$2,316,8220.01%
Ameritas Investment Partners, Inc. 6,461$216,5080.01%
Trexquant Investment LP 16,425$303,2060.01%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 46,089$8510.01%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.